LegiList
Congress, Made Clear.
Executive
Congress
Insights
States
My LegiList
API
Support LegiList
Home
Presidents
Orders
Proclamations
Statements
Vetoes
Home
Search
Topics
Campaign Finance
Home
Legislators
Bills
Categories
Analytics
Learn
Weekly Briefing
My LegiList
API
Executive
Home
Presidents
Orders
Proclamations
Statements
Vetoes
Congress
Home
Search
Topics
Campaign Finance
Insights
Analytics
Learn
Briefing
States
Home
Legislators
Bills
Categories
Support
Need all Congresses? Press Enter for expanded federal results.
Home
›
Congress
›
Bills
›
HR 1796
HR 1796
119th Congress • 2025-2027 (Current)
Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2025
Fact Sheet
Share
API
Pin
Bill Number
HR 1796
Introduced
Mar 3, 2025
Latest Action
Referred to the House Committee on Energy and Commerce.
Sponsor
Rep. John James (R-MI)
Cosponsors
Topics
Blood and blood diseases
Genetics
Health
Health promotion and preventive care
Hereditary and development disorders
Medical research
Research administration and funding
+4
...
Full Text
View Full Bill Text
Votes
Summary
No summary available.
Actions
Mar 3, 2025
Referred to the House Committee on Energy and Commerce.
Mar 3, 2025
Introduced in House
Amendments
Related Bills
S 735
Identical bill
S 891
Related bill
HR 1768
Related bill
HR 7148
Related bill